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Abstract
Introduction: Diabetes is a serious metabolic disorder and plenty of medical plants are used in traditional
medicines to treat diabetes. These plants have no side effects and many existing medicines are derived from the
plants. The purpose of this systematic review is to study diabetes and to summarize the available treatments for
this disease, focusing especially on herbal medicine.
Methods: Required papers about diabetes and effective plants were searched from the databases, including
Science direct, PubMed, Wiley, Scopus, and Springer. Keywords in this study are ”medicinal plants”, “diabetes”,
“symptom”, “herbal”, and “treatment”. Out of the 490 collected articles (published in the period between 1995
and 2015), 450 were excluded due to non-relevance or lack of access to the original article.
Results: Diabetes is mainly due to oxidative stress and an increase in reactive oxygen species that can have major
effects. Many plants contain different natural antioxidants, in particular tannins, flavonoids, C and E vitamins that
have the ability to maintain β-cells performance and decrease glucose levels in the blood.
Conclusion: According to published results, it can be said that medical plants are more affordable and have less
side effects compared synthetic drugs, and are more effective in treatment of diabetes mellitus.
Keywords: medicinal plants, diabetes, symptom, herbal, treatment
1. Introduction
Diabetes is a chronic disorder in the metabolism of proteins, fats, and carbohydrates (1, 2). It is described as an
increase in blood glucose after any type of meal. Diabetes results from either insulin deficiency or malfunction (2).
According to statistics, 2.8% of the world’s population suffer from this disease and it is expected to increase to more
than 5.4% by 2025 (3). Diabetes requires early diagnosis, treatment, and lifestyle changes.  Diabetes is a disease that
affects many people in the 21st century and is known as the fifth leading cause to death (4). High prevalence,
variable pathogenesis, progressive process, and complications of diabetes all highlight the urgent need for effective
treatments. Nowadays, different treatments, such as insulin therapy, pharmacotherapy, and diet therapy, are
available to control diabetes. There are several types of glucose-lowering drugs that exert anti-diabetic effects
through different mechanisms. These mechanisms include stimulation of insulin secretion by sulfonylurea and
meglitinides drugs, increasing of peripheral absorption of glucose by biguanides and thiazolidinediones (5), delay in
the absorption of carbohydrates from the intestine by alpha-glucosidase, and reduction of hepatic gluconeogenesis
by biguanides (6). In the past three decades, despite the significant progress made in the treatment of diabetes, the
results of treatment in patients is still far from perfect. These treatments have some disadvantages, including drug
resistance (reduction of efficiency), side effects, and even toxicity. For example, sulfonylureas lose their
effectiveness after 6 years of treatment in 44% of patients. It is also said that the glucose-lowering drugs are not able
to control hyperlipidemia (8). In addition, the side effects of medicines and their interactions with each other in vitro
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must be considered by medical staff. Today, many treatments that involve the use of medicinal plants are
recommended (9). Most plants contain carotenoids, flavonoids, terpenoids, alkaloids, glycosides and can often have
anti-diabetic effects (10). The anti-hyperglycemic effects that results from treatment with plants are often due to
their ability to improve the performance of pancreatic tissue, which is done by increasing insulin secretions or
reducing the intestinal absorption of glucose. The number of people with diabetes today has been growing and
causing increasing concerns in medical community and the public. The main purpose of this article is to introduce a
number of effective medicinal plants used for treating diabetes and other mechanisms of plant compounds used to
reduce glucose levels and increase insulin secretion.
2. Material and Methods
2.1. Materials
Publication regarding diabetes and effective plants were found in databases such as Science Direct, PubMed, Wiley,
Scopus, and Springer. Keywords used in this study included ”medicinal plants”, “diabetes”, “symptom”, “herbal”,
and “treatment”. Out of the 490 collected articles (published in the period between 1995 and 2015), 450 were
excluded due to non-relevance or lack of access to the original article.
2.2. Inclusion and exclusion criteria
The search was restricted to English and Persian language articles. All studies found during the search were
independently evaluated for competence and inclusion by two different authors. After compliance with inclusion
criteria, experimental research and clinical trials that evaluate the effect of medicinal herbs or plant component in
diabetic animals or patients were included in the current research. Irrelevant studies or original article that evaluated
mixed plant extract, algae, or mushroom extracts were also excluded.
3. Results and discussion
3.1. Acacia arabica
In a study that was done to evaluate the anti-diabetic activity of the acacia plant, oral administration of 200 mg/kg
and 100 mg/kg of Acacia arabica bark extract to streptozotocin (STZ)-induced diabetic rats over a 21 days period
increased serum insulin. In addition, high serum glucose and insulin resistance decreased, and the lipid profile
improved. This plant contains polyphenols, tannins, and flavonoids (for example, quercetin). The presence of these
substances with antioxidant properties is an explanation for anti-diabetic effects of this plant. The Acacia arabica
extract improves plasma glucose levels, metabolic disorders in lipid metabolism, and oxidative stress in STZ-
induced diabetic rats (11). Also, the chloroform extract of Acacia arabica bark was used for 2 weeks in diabetic rats,
significantly reduced the blood glucose level and improved the cholesterol, triglyceride, HDL, and LDL levels (12).
3.2. Achyranthes aspera
The ethanolic extract of Achyranthes aspera leaves (1000 mg/kg) used in STZ-induced diabetic rats significantly
reduced their blood glucose level. This is probably due to the inhibition of glucose absorption from the intestine or
because of an increase in glucose transport from the blood (13).
3.3. Acosmium panamense
Oral administration of doses of 200 and 20 mg/kg of aqueous Acosmium panamense extract and 100 and 20 mg/kg
doses of butanolic extract of the mentioned herb reduced the plasmas glucose level in STZ-induced diabetic rats
within 3 hours. The effects on hypoglycemic for the extract of this plant and glibenclamide (the main drug used to
treat diabetes) are similar (14).
3.4. Aegle marmelose
Oral administration of the aqueous extract dervied from Aegle marmelose fruit (125 and 250 mg/kg) in
streptozotocin diabetic Wistar rats twice daily for approximately 4 weeks caused a significant decrease in blood
glucose, plasma thiobarbituric acid reactive substances, hydroperoxides, ceruloplasmin, alpha-tocopherol, and a
considerable increase in plasma reduced glutathione, and vitamin C. The use of a 250 mg/kg dose of the extract was
more effective than glibenclamide in the improvement of these parameters. In this research, results clearly show the
hypoglycecmic activities of Aegle marmelose extract (15).
3.5. Allium sativum (garlic)
Anti-diabetic effects of ethanolic extracts derived from Allium sativum were measured in normal and streptozotocin
induced diabetic rats. Oral administration of the ethanolic extract of this plant for 14 days showed a reduction in the
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level of serum glucose, total cholesterol triglycerides, urea, uric acid, creatinine, AST (aspirate aminotransferase),
and ALT (aspirate aminotransferase). However, this extract increased the serum insulin in diabetic rats, but not in
normal ones. Comparing the performance of the garlic extract and 600 mg/kg of glibenclamide demonstrated that
the anti-diabetic activity of the extract is more effective than glibenclamide (16). In another study, it revealed that
oral administration of ethanolic extract, juice, and oil of ripe bulb of Allium sativum reduces the blood glucose in
STZ-induced diabetic rats by stimulating insulin secretion from pancreas cells. Daily oral administration of
100mg/kg of garlic extract significantly decreased plasma glucose levels by increasing plasma insulin levels (4).
3.6. Aloe barbadensis Miller
The Aloe barbadensis Miller plant, which is also known as Aloe vera, is used in traditional medicine by many
people. Treatment with the ethanolic extract of the fresh leaf gel from this plant (300 and 500 mg/kg) in STZ-
induced diabetic rats for 42 days resulted in a significant decrease in the fast blood glucose levels. The
hypoglycemic effect of this extract can be compared to standard anti-diabetic drugs (glibenclamide and metformin)
(17).
3.7. Andrographis paniculata
Oral administration of ethanolic extract derived from the aerial parts of Andrographis paniculata (different doses of
0.1, 0.2 and 0.4 g/BW) caused a significant reduction in levels of the serum glucose in STZ diabetic rats. However,
the effect was not seen in normal rats. This extract and anti-diabetic drugs dramatically reduced the activity of liver
glucose-6-phosphatase.  Further research has shown that the extract reduces the level of fasting serum triglyceride
by 49.8%, while metformin drugs reduces levels by 27.7%, but neither the extract or metformin affect cholesterol
levels. In addition, further studies concluded that the ethanolic extract of this plant has anti-diabetic activity that is
involved in the increase of glucose metabolism (18).
3.8. Annona squamosa
The aqueous extract of this plant leaf have many antioxidant effects. The blood glucose, haemoglobin, glycosylated
haemoglobin, plasma insulin, antioxidant enzymes, lipid peroxidation in liver and kidneys were examined in STZ-
induced diabetic rats. Oral administration of Annona squamosa aqueous extract for 30 days caused a significant
reduction in the blood glucose, lipids, and lipid peroxidation, but the activity of the plasma insulin and antioxidant
enzymes, like catalase and superoxide dismutase, increased.  On the other hand, the activity of glutathione and
glutathione peroxidase decreased.Generally, the aqueous extract of this plant is useful for controlling blood glucose
levels and improving plasma insulin and lipid metabolism. In addition, this extract is effective in preventing diabetic
complications caused by lipid peroxidation and antioxidant systems in experimental diabetic rats (19).
3.9. Argyreia nervosa
Oral administration of ethanolic extract of Argyreia nervosa root (500 mg/kg/BW) decreased blood glucose levels in
normoglycaemic rats. While loading rats with oral glucose for 2 hours, the glucose levels decreased from 118.45.4
to 96.44.2 mg/dl. After the consumption of the extract for 7 days in STZ diabetic rats, a significant anti-
hyperglycemic effect occurred (20).
3.10. Artemisia herba
Oral administration of aqueous extract derived from theaerial parts of this plant (0.39 g/kg/BW) for 2-4 weeks in
diabetic rats and rabbits caused a significant reduction in glucose levels and prevented an increase in the levels of
glycosylated haemoglobin. Furthermore, this plant has hypoliposis effects and can prevent weight loss in diabetic
animals (21).
3.11. Averrhova bilimbi
The hypolipidemic and hypoglycemic activity of ethanolic extract of Averrhova bilimbi leaves (ABE) was
investigated using STZ-induced diabetic rats. Diabetic rats were treated with distilled water, ABE (125mg/kg), or
metformin (500mg/kg) twice a day for two weeks. Like metformin, ABE, in comparison with distilled water,
significantly reduced the blood glucose level by 50% and the triglyceride level by 130%. In addition, ABE, in
comparison with distilled water, increased the concentration of HDL-cholesterol by 60%. It is important to note that
the extracts, like metformin, had no effects on the concentration of cholesterol and LDL-cholesterol, but
significantly decreased levels of lipid peroxidation. Research has revealed that ABE has hypoglycemic,
hypotriglyceridemic, anti-lipid per oxidative, and anti-atherogenic activities in STZ-induced diabetic rats (22).
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3.12. Azadirachta indica
Administration of the leaf extract and seed oil for 4 weeks reduced the blood glucose levels in alloxan diabetic
rabbits. This extract had similar effects as the anti-diabetic drug glibenclamide. The neem extract can control blood
glucose and appears to be helpful in preventing or delaying the onset of diabetes (23). In another study, the anti-
diabetic effects of the neem was evaluated and it was found that the administration of a single dose of aqueous
extract of the bark and root (250 mg/kg) can decrease urea (13%), triglycerides (32%), cholesterol (15%), glucose
(18%), lipids (15%), and creatinine (23%) in diabetic rats (24) for 24 hours after treatment.
3.13. Barleria prionitis
Anti-diabetic activities of Barleria prionitis were studied in normal and alloxan induced diabetic rats. The use of the
alcoholic extract of this leaf (200 mg/kg) for 14 days created a significant reduction in blood glucose and
glycosylated hemoglobin levels, while a substainal increase occurred in the levels of insulin and liver glycogen. This
extract prevented weight loss in the experimental subjects (25). In another study, the extract of the plant leaves and
roots lead to a significant decrease in blood glucose level in diabetic rats (26).
3.14. Biophytum sensitivum
The Biophytum genus from the Oxalidaceae family is also known as a life plant. The extract of this plant has amino
acids, steroids, terpenes, tannins, saponins, flavonoids, polysaccharides, oil essential, and pectin. Studies assessing
the hypoglycemic activity of Biophytum sensitivum showed that oral administration of this plant (200 mg/kg) for
approximatly 28 days can lead to a significant decrease in blood glucose and glycosylated haemoglobin levels in
normal and steptozotonic-nicotinamide-induced diabetic rats. Also, it can cause a significant increase in the total
hemoglobin, plasma insulin, and liver glycogen in diabetic rats. Due to the extract effects, the activity of glucose 6-
phosphatase increased, and fructose- 1-6 bisphosphatase activity was reduced in diabetic rats (27). According to
published observations, it is most likely that the hypoglycemic responses to Biophytum sensitivum is because of the
synthesis or secretion of insulin from Beta-cells (28).
3.15. Brassica nigra
In a recent study, the anti-diabetic activity of this plant was obvious. Treatment of STZ-induced diabetic rats with
aqueous extract of the seed (200mg/kg/BW) once a day for 30 days decreased the fasting blood glucose level.  In
addition, there was a poor increase in the glycosylated hemoglobin and serum lipids levels for the treated group (29).
3.16. Bryonia alba
Laboratory studies state that oral administration of ethanolic extract of Bryonia alba root (200mg/kg) for 7 days
causes a significant decrease in glucose level in alloxan-induced diabetic rats. Also, these studies confirmed the
historic claims about the anti-diabetic activity of the plant (30).
3.17. Caesalpinia bonducella
This plant has anti-nociceptive, anxiolytic, anti-filarial, and anti-diarrhoeal activities. Phytochemical analysis
determined the presence of alkaloids, flavonoids, glycosides, saponins, tannins, and triterpenoids in this plant (31).
Oral administration of the plant seed extract (300mg/kg) caused a tangible anti-hyperglycemic effect in alloxan-
induced hyperlipidemia and decreased the BUN level. This extract caused a significant reduction in cholesterol
levels and increased LDL levels in diabetes induced hyperlipidemia. The anti-diabetic actions of the extract is
thought to be due to glucose absorption blockage (32). In another study, hypoglycemic activities of aqueous extract
was examined in normal and STZ diabetic rats. Administration of 100 mg/kg doses showed hypoglycemic activity
and the effects of aqueous extract was longer than ethanolic extracts. After the fifth day, both extracts caused a
remarkable hypoglycemic activity in diabetic rats (33).
3.18. Cajanus cajan
This plant is used in Panamanian culture as a medicinal plant for treating diabetes. Different parts of the plants are
used in Africa, Asia, and South America to control disorders, including ulcer, diarrhea, pain, diabetes, cough, and
sores. Among the four tested extracts of this plant, viz petroleum ether, choloroform, ethyl aceate, and methanol
extract, only ethyl acetate and methanolic extracts decreased glucose levels, and reached 27.09% and 37.68% by
oral administration of 250mg/kg for 10 days in diabetic mice. Also, insulin decreased blood glucose levels by
32.66%. These two extracts increased insulin activity and the simultaneous use of ethyl acetate and methanolic
extracts caused a reduction in blood glucose levels, by 43.07% and 48.14%, respectively. It was concluded that these
two extracts of the Cajanus cajan plant are more likely to have anti-diabetic bioactive components (34). Another
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study found that aqueous extracts of leaves and stems of this plant do not reduce the blood glucose level in
normoglycemic mice and the doses of 1000 and 500 mg/kg have hyperglycemia effects. The only dose that caused a
significant reduction in the blood glucose level in a short time was 300 mg/kg (35).
3.19. Carum carvi
The hypoglycemic effects of aqueous extracts of Carum carvi fruit and Capparis spinosa were determined in normal
and streptozotocin (STZ) diabetic rats. Oral administration of a single dose or the consumption daily of 14 doses of
aqueous extracts of these plants cause a significant reduction in blood glucose levels in STZ diabetic rats. Blood
glucose levels were normal approximately 2 weeks after the use of both extracts. In addition, no changes in plasma
insulin concentrations were observed after the treatment in normal or STZ diabetic rets. It seems that the
mechanisms of action for these plants are independent on insulin secretions. In fact, the anti-hyperglycemic
activities of aqueous extracts from Carum carvi and Capparis spinosa in diabetic rats STZ occur without affecting
the basal plasma insulin concentration (36).
3.20. Casearia esculenta
Casearia esculenta is a native anti-diabetic plant used in southern India. The extract reduces blood glucose levels in
normal and STZ-induced diabetic rats. Oral administration of aqueous extract from the plant root (300 mg/kg/BW)
shows high antioxidant activity, and therefore provides anti-oxidant protection in STZ-induced diabetic rats (37).
Another study done to evaluate the anti-diabetic activities of extract in normal and streptozonic induced diabetic rats
found that oral administration of aqueous extract of Casearia sculenta (300 mg/kg/BW) for 45 days significantly
reduced  blood glucose levels. Also, treatment with this plant can lead to a reduction in glucose 6-phosphatase,
fructose-1,6 bis phosphatase activity, and increases  liver hexokinase activity (38).
3.21. Chamaemelum nobile
The study of anti-diabetic activities of Chamaemelum nobile demonstrated that oral administration of a single dose
of 20 mg/kg aqueous extract of this plant for 15 days caused a significant decrease in blood glucose levels in normal
and STZ diabetic rats (39).
3.22. Cichorium intybus
In India, the ethanolic extract of Cichorium intybus (CIE) is a traditional treatment for diabetes. A 125mg/kg/BW
dose of CIE showed the most effective hypoglycemic activity. Daily administration of this dose for 14 days caused a
reduction in triglycerides levels by 91%, serum glucose by 20%, and total cholesterol by 16%. However, there
weren’t any changes in the density of plasma insulin. Extract of CIE, in comparison with the control group,
decreased glucose-6-phosphatase activity and led to a reduction in the production of hepatic glucose. Also, it
decreased the blood glucose levels in diabetic rats treated with this extract (40). In other research, it was determined
that aqueous extract of the CIE seed (125mg/kg/BW) used for 28 days prevented weight loss in STZ diabetic rats
and caused  the reduction of fasting blood glucose. In the treated group with CIE, the activity of sera for ALT and
the level of triglyceride, TC, and HbA1c decreased. However, there was an increase in the density of nitric oxide
(41).
3.23. Citrulus colocynthis
In a recent study evaluating the effects of a 200 mg/kg dose of Citrulus colocynthis extract on the glucose, insulin,
and the insulin resistance index (FIRI), it was observed that the aqueous extract of the seed of this fruit reduced the
glucose level and increases serum insulin, while the hydro-alcoholic extract of the peel increases the glucose level
and decreases serum insulin. The most effective part of this fruit in treating type 2 diabetes is the seed, while the
peel is harmful for diabetes treatment (42).
3.24. Coriandrum sativum
Anti-diabetic activity of the aqueous extract of this plant was examined in STZ-induced diabetic rats. Doses of 500
and 250 mg/kg of extract caused a significant reduction in blood glucose levels in the experimental group, compared
to the control group. In addition, the dose of 500 mg/kg was the maximally effective (43).
3.25. Dorema aucheri
In a study on the anti-diabetic and hypoglycemic effects of hydro-alcoholic extract of Dorema aucheri leaves
(100,200 and 400 mg/kg/BW) in nicotinamide streptozotocin induced type 2 diabetic rats, it was found that the
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administration of  the extract  in the diabetic group had anti-hyperglycemic effects and  salutory effects on the lipid
profile and on the livers enzyme activities. A dose of 200 mg/kg was more effective than other tested doses.
Flavonoids are often considered to be an important component of this plant and this is demonstrated by the extracts
role in the reduction of oxidative stress in B-cells and the improvement of their performance (44).
3.26. Eclipta alba
Eclipta Alba is an herbaceous plant found in the tropical and subtropical regions of South America, Asia, and Africa.
Many chemical compounds, including flavonoids, alkaloids, tryterpens, and other glycosides, have been purified
from this plant (45). It is considered to be an important hypoglycemic agent in rural areas of southern India. Oral
administration of leaf suspension of E. alba (2 and 4 gr/kg) for 60 days caused a significant reduction in blood
glucose, glycosylated hemoglobin, glucose-6-phosphatase, and fructose-1, 6 bisphosphatase in alloxan-induced
diabetic rats, however the hexokinase concentrations in the liver increased (46).
3.27. Fraxinus excersior
Intravenous injection of the aqueous extract from Fraxinus excersior (10 mg/kg) caused a tangible reduction in
blood glucose levels in normal and streptozotocin-induced diabetic rats. The extract led to a high level of control for
renal glucose, which can explain by the hypoglycemic activities of the extract (47). Another study, based on the anti -
diabetic actions of Fraxinus excersior, showed oral administration of a single dose or 15 daily doses of the aqueous
extract (20mg/kg) caused a significant reduction in blood glucose levels without changing the basal concentration of
insulin (48).
3.28. Helicteres isora
The effect of the aqueous extract of the Helicteres isora fruit on the absorption of glucose was examined in the
skeletal muscle cells of rodents. A dose of 200 mg/kg increased the absorption of blood glucose in studied cells (49).
3.29. Hypoxis hemerocallidea
The hypoglycemic effects of aqueous extract from Hypoxis hemerocallidea (belonging to the Hypoxidaceae family,
named after the African potato) were examined in normal and in streptozotocin (STZ) treated rats. An extract dose
of 800 mg/kg lead to a 48.54% reduction in normal rats blood glucose, with a 30.20% reduction in STZ treated
diabetic rats (50).
3.30. Lepidium sativum
Anti-diabetic activities of the aqueous extract of the plant seeds were studied in normal and streptozonic (STZ)
diabetic rats. After oral administration of a single dose (acute) or 15 times daily (chronic) of the above extract
(20mg/kg), the blood glucose level significantly decreased in STZ-induced diabetic rats. After 2 weeks of chronic
treatment, the glucose level did not change the basal concentration of insulin and returned to a normal state (51).
3.31. Mangifera indica
The anti-diabetic properties of Mangifera indica leaves were evaluated in glucose induced normoglycaemic,
hyperglycaemic, and streptozotocin induced diabetic rats. The aqueous extract of this plant leaf decreased the
glucose level in normoglycaemic and glucose induced hyperglycemia, however it did not demonstrate any effects on
the STZ-induced diabetic mice group. The hypoglycemic effects of the extract are comparable with an oral dose of
chlorpromide under the same conditions (52). In another study, during the treatment of diabetic rats with mango peel
powder (MPP), there was an increase in the antioxidant activity and lipid peroxidation in the plasma, liver, and
kidney decreased. Also, the glomerular filtration rate and micro albuminuria level improved with MPP treatment
(53). The oral administration of the plant leaf (1 g/kg) did not change the blood glucose level in normoglycaemic or
in STZ-induced diabetic rats, but, when the extract and glucose is administrated at the same time, the anti-diabetic
activity of the extract is observable. The anti-diabetic activity of the extract in this study is probably due to reduced
intestinal absorption of glucose (54).
3.32. Myrcia bella
This plant belongs to the Myrtaceae family and has been used by Brazilian indigenous people as a traditional
medicine as an astringent, or diuretic, and in treatments for hypertension and diabetes. The hypoglycemic effects of
a 70% ethanolic extract of the plant leaves were investigated in diabetic rats. During a fourteen-day treatment with
extract of the plant leaf (300 or 600 mg/kg/BW), fasting blood glucose was measured weekly. The treatment with ta
600 mg/kg dose decreased the fasting blood glucose during the seventh day in diabetic mice while cholesterol and
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triglyceride levels decreased in the treated diabetic group, but glycogen and the expression of IRS-1, PI3-K, and
AKT in the liver increased. These results proved that the extract has hypoglycemic properties and functions by
regulating glucose consumption by the liver (55).
3.33. Nigella sativa
In the study on anti-diabetic activity of Nigella sativa seeds, oral administration of plant capsules (at a dose of
2gr/day) significantly reduced FBG, 2 HPG, and HBA1 activities without changing the body weight of the sujects.
The results of this study confirmed that applied doses can be used as an adjuvant therapy in type 2 diabetic people
(56).
3.34. Ocimum sanctum
The leaves of this plant are traditionally used in treating diabetes. Consuming doses of Ocimum sanctum (OS) leaf at
2 gr/kg for 30 days in the group of albino rabbits caused a sharp reduction in glucose level and the level of
antioxidant enzymes and glutathione increased, while lipid peroxidation decreased by using the plant leaf. For this
reason, the hypoglycemic activity of the plant is believed to be related to the adjustment of the cellular
antioxidant system (57). In another study, the ethanolic extract of OS leaves caused a significant reduction in blood
glucose levels in normal and alloxan-induced diabetic rats (58).
3.35. Origanium vulgare
Oral administration of aqueous extract of the leaves of this plant (20mg/kg), in comparison with the standard drug
glibenclamid (0.9 mg/kg/BW), caused a significant reduction in glucose level, glycosylated hemoglobin, and
pancreatic amylase in STZ diabetic rats. Treatment with the extract decreased the liver/body weight ratio in diabetic
rats, while the ratio of the kidney/body weight, the level of urea, uric acid, and creatinine improved slightly. Oral
administration at the mentioned doses modified the reduction of body insulin, muscle, liver glycogen content, and
body weight in STZ diabetic rates (59).
3.36. Phyllanthus amarus
Phyllanthus amarus is a medicinal plant known as a hypoglycemic factor in central and southern India. Oral
administration of ethanolic extract from the leaves (400 mg/kg/BW) for 45 days caused a significant reduction in
blood glucose levels in alloxan-induced diabetic mice and led to a significant improvement in the body weight of
diabetic mice. Also, there was a reduction in glucose-6-phosphatase and fructose 1, 6 di phosphatase activities in the
liver. The glucokinase activity, in comparison with control group, increased during treatment in the liver of the
diabetic rats (60).
3.37. Prangos ferulacea (L.) lindl.
This plant is used in traditional medicine to relieve pain, inflammation, and help treat diabetes. The major
components of extracts from this plant are monoterpenes compounds. The presence of monoterpenes,
sesquiterpenes, coumarins, flavonoids, tannins, saponins, alkaloids, terpenoids, and antioxidants are factors in the
antioxidant, anti-diabetic, anti-microbial, anti-viral, and antispasmodic properties (61). In a study on the properties
of this plant, it was found that, in diabetic rats, a dose of 100mg/kg of the hydro-alcoholic extract of plant root
causes a significant reduction in blood glucose levels, total cholesterol, triglyceride, LDL, glycosylated hemoglobin,
and a significant increase in HDL levels. In addition, it adjusts the number of white blood cells to normal. This
extract is also effective in improving liver and kidney damages and leads to a significant increase in blood indicators
of liver function, such as creatinine, AST, and ALT (62).
3.38. Rhus coriaria (sumac)
Effects of sumac seeds on reproductive systems were examined in nicotinamide streptozotcin induced type 2
diabetic rats. Glibendamide and sumac extract were used orally for 28 days. The weight of the body and testis,
number and viability of sperm, and the level of luteinizing hormone of serum, follicle, and testosterone significantly
decreased in diabetic rats, but this reduction was alleviated in diabetic rats treated with the above extract (400mgkg).
Glibenclamide also helped recovery of the reduction of sperm count and hormones in diabetic rats (63).
3.39. Salacia reticulate
The effects of Salacia reticulate aqueous extract on glucose absorption were examined in normal type 1 diabetic
mice. Simultaneous oral administration of the extract (1mg/kg) with maltose or sucrose lead to increased levels of
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plasma glucose after a meal (postprandial), and inhibited insulin and intestinal alpha glycosidase activities in the
mice. Also, a 0.01 solution of the extract given as drinking water prevented an increase in insulin glucose levels and
intestinal alpha glycosidase activities in type 1 diabetic mice. This treatment helped prevent an increase of lipid
peroxidation in the plasma, pancreas, and kidney and prevented a decrease in plasmas insulin level and anincrease in
aldose reductase activity in kidney (64).
3.40. Securinegra virosa
The anti-diabetic effects of the methanolic extract of the leaves of Securinegra virosa was examined in streptozocin
induced diabetes rats. Intraperitoneal administration of 3 doses (100, 300, 600mg/kg) of the extract were
administered and after 2 hours, no changes in blood glucose level were observed with all 3 doses. After 4, 8, and 24
hours, all doses caused a significant reduction in glucose level in the experimental group. This extract may increase
the absorption and metabolism of glucose or may inhibit the hepatic gluconeogenesis (65).
4. More in-depth discussion
Diabetes is considered to be a metabolic disorder that mainly occurs due to defects in either insulin secretion, insulin
action, or both. Diabetes is a disease that can lead to serious problems affecting human health. In the long term,
effects can causes micro and macro vascular problems (66). In addition, uncontrolled diabetes can cause many
chronic complications, including blindness, heart disease, and renal failure (67). A significant change occurs in the
structure and metabolism of lipid in diabetes. Lipid peroxidation is associated with hyperlipidemia. The liver plays a
critical role in glucose, lipid homeostasis, and has an important effect on diabetes. The liver and kidneys participate
in the absorption, oxidation, and metabolism of free fatty acids and synthesize cholesterol, phospholipids, and
triglycerides. Despite the presence of anti-diabetic drugs in the pharmaceutical market, the treatment of diabetes
with medicinal plants is often successful. Herbal medicines and plant components with insignificant toxicity and no
side effects are notable therapeutic options for the treatment of this disease around the world (12). Most tests have
demonstrated the benefits of medicinal plants containing hypoglycemic properties in diabetes management. The
most common herbal active ingredients used in treating diabetes are flavonoids, tannins, phenolic, and alkaloids
(67). The existence of these compounds implies the importance of the anti-diabetic properties of these plants (12).
For example, tannin improves the function of pancreatic Beta-cells and increases insulin secretion. Quercetin is an
antioxidant that acts in several mechanisms related with the removal of oxygen radicals, so prevents lipid
peroxidation and metal ion chelation (12). In fact, the mechanisms of actions for hypoglycemic plants include:
increasing of insulin secretion, increasing of glucoses absorption by muscle and fat tissues, prevention of glucose
absorption from the intestine, and prevention of glucose production from liver cells (11). These factors are mostly
responsible for the reduction or elimination of diabetes complications. It is worth noting that in this study, STZ rats
are the most common animal model used to investigate anti-diabetic activity of plant extracts.
5. Conclusions
Plants are natural antioxidants and effective herbal medicines, in part due to their anti-diabetic compounds, such as
flavonoids, tannins, phenolic, and alkaloids that improve the performance of pancreatic tissues by increasing the
insulin secretion or decreasing the intestinal absorption of glucose. More researches are needed in order to separate
the active components of plants and molecular interactions of their compounds for analysis of their curative
properties.
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